HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liemei Guo Selected Research

Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))

11/2018Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liemei Guo Research Topics

Disease

10Neoplasms (Cancer)
03/2021 - 07/2014
6Glioblastoma (Glioblastoma Multiforme)
01/2020 - 02/2015
5Hypoxia (Hypoxemia)
11/2019 - 10/2013
4Glioma (Gliomas)
01/2020 - 02/2015
4Ischemia
01/2019 - 01/2012
3Aneurysm (Aneurysms)
07/2014 - 03/2014
2Meningioma (Meningiomas)
03/2021 - 10/2019
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019 - 10/2013
2Neuroblastoma
01/2017 - 10/2013
2Brain Ischemia (Cerebral Ischemia)
07/2014 - 01/2012
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Brain Infarction
01/2019
1Stroke (Strokes)
01/2019
1Hypertension (High Blood Pressure)
11/2017
1Brain Edema (Cerebral Edema)
11/2017
1Cerebral Hemorrhage
11/2017
1Chemical Burns (Chemical Burn)
01/2017
1Retinoblastoma (Glioblastoma, Retinal)
10/2015
1Ophthalmoplegia (External Ophthalmoplegia)
07/2014
1Moyamoya Disease (Moya-Moya Disease)
07/2014
1Hemorrhage
05/2014
1Prolactinoma (Prolactinomas)
05/2014
1Pica (Geophagia)
03/2014
1Substance-Related Disorders (Drug Abuse)
04/2013
1Neoplasm Metastasis (Metastasis)
11/2012
1Necrosis
01/2012

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2013
3Biological ProductsIBA
01/2020 - 01/2019
3Long Noncoding RNAIBA
01/2020 - 01/2019
2Carbonic Anhydrase IXIBA
01/2020 - 11/2019
2Chimeric Antigen ReceptorsIBA
01/2020 - 11/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 05/2015
1Metformin (Glucophage)FDA LinkGeneric
03/2021
1Cisplatin (Platino)FDA LinkGeneric
03/2021
1LB100IBA
01/2020
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
12/2019
1LuciferasesIBA
12/2019
1Interleukin-2 (IL2)IBA
11/2019
1AntigensIBA
11/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2019
1Interferon-gamma (Interferon, gamma)IBA
11/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1Oxygen (Dioxygen)IBA
01/2019
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2018
1PlatinumIBA
01/2017
1Cantharidin (Cantharides)IBA
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1Liposomes (Liposome)IBA
01/2017
1ProdrugsIBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
10/2015
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
10/2015
1Lactic Acid (Lactate)FDA LinkGeneric
05/2015
1EnzymesIBA
05/2015
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
05/2015
1isocitric acid (isocitrate)IBA
05/2015
1Amino AcidsFDA Link
05/2015
1HexokinaseIBA
05/2015
1Arginine (L-Arginine)FDA Link
05/2015
1Mannose (D-Mannose)IBA
02/2015
1protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA
02/2015
1Peptides (Polypeptides)IBA
02/2015
1GlycosyltransferasesIBA
02/2015
1CateninsIBA
02/2015
1Bromocriptine (Parlodel)FDA LinkGeneric
05/2014
1Messenger RNA (mRNA)IBA
10/2013
1cobaltous chloride (cobalt(II)chloride)IBA
10/2013
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
01/2012
1Glutamic Acid (Glutamate)FDA Link
01/2012
1Excitatory Amino AcidsIBA
01/2012

Therapy/Procedure

3Craniotomy
01/2020 - 11/2017
3Therapeutics
01/2017 - 05/2014
2Radiotherapy
07/2014 - 11/2012
1Ventriculoperitoneal Shunt
11/2017
1Catheters
11/2017
1Ligation
07/2014
1Operative Surgical Procedures
05/2014
1Stents
03/2014
1Deep Brain Stimulation
04/2013
1Drug Therapy (Chemotherapy)
11/2012